Cargando…
Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee
This study measured the exposure to different categories of medicinal products discussed by the European Union (EU) Pharmacovigilance Risk Assessment Committee from September to November 2018 in four electronic primary care health databases: IQVIA Medical Research Data‐UK, IQVIA Medical Research Dat...
Autores principales: | Flynn, Robert, Hedenmalm, Karin, Murray‐Thomas, Tarita, Pacurariu, Alexandra, Arlett, Peter, Shepherd, Hilary, Myles, Puja, Kurz, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158204/ https://www.ncbi.nlm.nih.gov/pubmed/31955404 http://dx.doi.org/10.1002/cpt.1775 |
Ejemplares similares
-
Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent
por: Okoli, Grace N., et al.
Publicado: (2021) -
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works
por: Santoro, Aniello, et al.
Publicado: (2017) -
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children
por: Candore, Gianmario, et al.
Publicado: (2020) -
Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics
por: Arlett, Peter, et al.
Publicado: (2019) -
A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children
por: Hedenmalm, Karin, et al.
Publicado: (2019)